Evidence map›Paper›PMID 22437241›Full record

ArticlePathology oncology research : POR2012

Menthol inhibits the proliferation and motility of prostate cancer DU145 cells.

Yongzhi Wang, Xinghuan Wang, Zhonghua Yang, Guangbin Zhu, Dong Chen, Zhe Meng

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 83 citations in OpenAlex.

  1. CaCurrent research in toxicology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Intracellular CaFrontiers in physiology · 2023
    Review
  11. Review
  12. Menthol: An underestimated anticancer agent.Frontiers in pharmacology · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yongzhi WangDepartment of Urology, Zhongnan Hospital, Wuhan University, Number 169, Donghu Road, Wuhan, Hubei, People's Republic of China.
Xinghuan Wang
Zhonghua Yang
Guangbin Zhu
Dong Chen
Zhe Meng
Wuhan University · CNZhongnan Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent.

Indexed as

Calcium ChannelsCell Cycle CheckpointsCell Line, TumorCell MovementCell ProliferationCyclin-Dependent KinasesDown-RegulationHumansImmunohistochemistryMaleMentholNerve Tissue ProteinsProstatic NeoplasmsTransient Receptor Potential ChannelsTRPA1 Cation ChannelTRPM Cation ChannelsCalcium ChannelsCyclin-Dependent KinasesMentholNerve Tissue ProteinsTransient Receptor Potential ChannelsTRPA1 Cation ChannelTRPA1 protein, humanTRPM8 protein, humanTRPM Cation Channels

Identifiers

PMID22437241
OpenAlexW2083353518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.